Liaoning Chengda Biological Co., Ltd.

2017Annual Results Express Announcement

Special tips:contained in this announcement2017The main financial data for the year is preliminary accounting data, which has not been audited by an accounting firm.2017The data disclosed in the annual report shall prevail, drawing investors' attention to investment risks.

1.2017Annual key financial data and indicators

Unit: Yuan

Note:1The. The beginning of the reporting period is the same as the statutory disclosure at the end of the previous year.

2. The above data is filled in with consolidated report data.

II. Statement of results of operations and financial position

2017Year, the company around the annual business strategy planning.,Firmly seizing the market opportunity of the recovery of the vaccine industry, timely adjusting the marketing strategy and building a distribution system, the market sales of human rabies vaccine and inactivated Japanese encephalitis vaccine for human use increased significantly compared with the same period last year; with the implementation of the revised regulations on the Administration of Vaccine Circulation and vaccination, the company has strictly regulated the sales and procurement of vaccines in the vaccine market. The company actively cooperates with relevant institutions to bring vaccines into the provincial public resources trading platform for centralized procurement.

During the reporting period, the company steadily promoted various businesses, maintained good financial indicators and further enhanced profitability. Realize operating income127,603.98Ten thousand yuan, year-on-year growth23.93%; Total realized profit65,982.53Ten thousand yuan, year-on-year growth21.36%; Net profit attributable to shareholders of the listed company55,928.61Ten thousand yuan, year-on-year growth22.36%。

As of the end of the reporting period, the Company's total assets were278,499.59Ten thousand yuan, year-on-year growth9.81%The owner's equity attributable to the shareholders of the listed company is252,416.35Ten thousand yuan, year-on-year growth7.89%. The company's total assets and owner's equity attributable to shareholders of listed companies increased year-on-year, mainly due to the new profits during the reporting period.

3. Risk Alert

This performance report is the result of preliminary accounting by the company's financial department, which has not been audited by an accounting firm.2017Detailed disclosure in the annual report. Please the majority of investors cautious decision-making, pay attention to investment risk.

IV. Documents for Reference

A comparative balance sheet and income statement signed and sealed by the company's current legal representative, the person in charge of accounting, and the head of the accounting organization (accounting officer).

It is hereby announced.